Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015

GBD 2015 LRI Collaborators, Christopher Troeger, Mohammad Forouzanfar, Puja C Rao, Ibrahim Khalil, Alexandria Brown, Scott Swartz, Nancy Fullman, Jonathan Mosser, Robert L Thompson, Robert C Reiner Jr, Amanuel Abajobir, Noore Alam, Mulubirhan Assefa Alemayohu, Azmeraw T Amare, Carl Abelardo Antonio, Hamid Asayesh, Euripide Avokpaho, Aleksandra Barac, Muktar A Beshir, Dube Jara Boneya, Michael Brauer, Lalit Dandona, Rakhi Dandona, Joseph R A Fitchett, Tsegaye Tewelde Gebrehiwot, Gessessew Buggsa Hailu, Peter J Hotez, Amir Kasaeian, Tawfik Khoja, Niranjan Kissoon, Luke Knibbs, G Anil Kumar, Rajesh Kumar Rai, Hassan Magdy Abd El Razek, Muktar S K Mohammed, Katie Nielson, Eyal Oren, Abdalla Osman, George Patton, Mostafa Qorbani, Hirbo Shore Roba, Benn Sartorius, Miloje Savic, Mika Shigematsu, Bryan Sykes, Soumya Swaminathan, Roman Topor-Madry, Kingsley Ukwaja, Andrea Werdecker, Naohiro Yonemoto, Maysaa El Sayed Zaki, Stephen S Lim, Mohsen Naghavi, Theo Vos, Simon I Hay, Christopher J L Murray, Ali H Mokdad, GBD 2015 LRI Collaborators, Christopher Troeger, Mohammad Forouzanfar, Puja C Rao, Ibrahim Khalil, Alexandria Brown, Scott Swartz, Nancy Fullman, Jonathan Mosser, Robert L Thompson, Robert C Reiner Jr, Amanuel Abajobir, Noore Alam, Mulubirhan Assefa Alemayohu, Azmeraw T Amare, Carl Abelardo Antonio, Hamid Asayesh, Euripide Avokpaho, Aleksandra Barac, Muktar A Beshir, Dube Jara Boneya, Michael Brauer, Lalit Dandona, Rakhi Dandona, Joseph R A Fitchett, Tsegaye Tewelde Gebrehiwot, Gessessew Buggsa Hailu, Peter J Hotez, Amir Kasaeian, Tawfik Khoja, Niranjan Kissoon, Luke Knibbs, G Anil Kumar, Rajesh Kumar Rai, Hassan Magdy Abd El Razek, Muktar S K Mohammed, Katie Nielson, Eyal Oren, Abdalla Osman, George Patton, Mostafa Qorbani, Hirbo Shore Roba, Benn Sartorius, Miloje Savic, Mika Shigematsu, Bryan Sykes, Soumya Swaminathan, Roman Topor-Madry, Kingsley Ukwaja, Andrea Werdecker, Naohiro Yonemoto, Maysaa El Sayed Zaki, Stephen S Lim, Mohsen Naghavi, Theo Vos, Simon I Hay, Christopher J L Murray, Ali H Mokdad

Abstract

Background: The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2015 provides an up-to-date analysis of the burden of lower respiratory tract infections (LRIs) in 195 countries. This study assesses cases, deaths, and aetiologies spanning the past 25 years and shows how the burden of LRI has changed in people of all ages.

Methods: We estimated LRI mortality by age, sex, geography, and year using a modelling platform shared across most causes of death in the GBD 2015 study called the Cause of Death Ensemble model. We modelled LRI morbidity, including incidence and prevalence, using a meta-regression platform called DisMod-MR. We estimated aetiologies for LRI using two different counterfactual approaches, the first for viral pathogens, which incorporates the aetiology-specific risk of LRI and the prevalence of the aetiology in LRI episodes, and the second for bacterial pathogens, which uses a vaccine-probe approach. We used the Socio-demographic Index, which is a summary indicator derived from measures of income per capita, educational attainment, and fertility, to assess trends in LRI-related mortality. The two leading risk factors for LRI disability-adjusted life-years (DALYs), childhood undernutrition and air pollution, were used in a decomposition analysis to establish the relative contribution of changes in LRI DALYs.

Findings: In 2015, we estimated that LRIs caused 2·74 million deaths (95% uncertainty interval [UI] 2·50 million to 2·86 million) and 103·0 million DALYs (95% UI 96·1 million to 109·1 million). LRIs have a disproportionate effect on children younger than 5 years, responsible for 704 000 deaths (95% UI 651 000-763 000) and 60.6 million DALYs (95ÙI 56·0-65·6). Between 2005 and 2015, the number of deaths due to LRI decreased by 36·9% (95% UI 31·6 to 42·0) in children younger than 5 years, and by 3·2% (95% UI -0·4 to 6·9) in all ages. Pneumococcal pneumonia caused 55·4% of LRI deaths in all ages, totalling 1 517 388 deaths (95% UI 857 940-2 183 791). Between 2005 and 2015, improvements in air pollution exposure were responsible for a 4·3% reduction in LRI DALYs and improvements in childhood undernutrition were responsible for an 8·9% reduction.

Interpretation: LRIs are the leading infectious cause of death and the fifth-leading cause of death overall; they are the second-leading cause of DALYs. At the global level, the burden of LRIs has decreased dramatically in the last 10 years in children younger than 5 years, although the burden in people older than 70 years has increased in many regions. LRI remains a largely preventable disease and cause of death, and continued efforts to decrease indoor and ambient air pollution, improve childhood nutrition, and scale up the use of the pneumococcal conjugate vaccine in children and adults will be essential in reducing the global burden of LRI.

Funding: Bill & Melinda Gates Foundation.

Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Global distribution of LRI mortality LRI mortality rate per 100 000 people in children younger than 5 years (A) and all ages (B) in 2015. Percent change in LRI deaths per 100 000 people between 2005 and 2015 in children younger than 5 years (C) and in all ages (D). LRI=lower respiratory tract infection. ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. FSM=Federated States of Micronesia. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste.
Figure 1
Figure 1
Global distribution of LRI mortality LRI mortality rate per 100 000 people in children younger than 5 years (A) and all ages (B) in 2015. Percent change in LRI deaths per 100 000 people between 2005 and 2015 in children younger than 5 years (C) and in all ages (D). LRI=lower respiratory tract infection. ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. FSM=Federated States of Micronesia. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste.
Figure 2
Figure 2
LRI burden by Global Burden of Diseases Study region plotted against SDI Under-5 LRI mortality rate per 100 000 (A) and incidence per child-year (B) is shown. Data points show 5-year increments from 1990 to 2015. The black line is a least-squares cubic spline regression, with knots at 0·4, 0·6, and 0·8, using the under-5 LRI mortality rate or incidence for each geographic location, and represents the expected rate based on SDI alone (estimates above the black line are higher than expected and those below are lower than expected). More information on the formulation and theory of the SDI can be found in the Cause of Death GBD 2015 capstone paper. LRI=lower respiratory tract infection. SDI=Sociodemographic Index.
Figure 3
Figure 3
Attributable fraction of LRI mortality in children younger than 5 years in 2015 Aetiologies for each GBD region are ordered by the global ranking. Numbers show the population attributable fraction in 2015, and colours show the percent change from 2005 to 2015. LRI=lower respiratory tract infection.
Figure 4
Figure 4
Risk factor decomposition of the change in attributable DALYs in all ages between 2005 and 2015 (A) Southeast Asia, east Asia, and Oceania; (B) north Africa and Middle East; (C) south Asia; (D) central Europe, eastern Europe, and central Asia; (E) sub-Saharan Africa; (F) Latin America and Caribbean; and (G) high-income WHO regions. Black dots show the overall percentage change in LRI DALYs and colours show contribution of different factors to the rate of change. Bars to the left of zero show a reduction in attribution and bars to the right show an increase. LRI=lower respiratory tract infection. DALY=disability-adjusted life-year.
Figure 4
Figure 4
Risk factor decomposition of the change in attributable DALYs in all ages between 2005 and 2015 (A) Southeast Asia, east Asia, and Oceania; (B) north Africa and Middle East; (C) south Asia; (D) central Europe, eastern Europe, and central Asia; (E) sub-Saharan Africa; (F) Latin America and Caribbean; and (G) high-income WHO regions. Black dots show the overall percentage change in LRI DALYs and colours show contribution of different factors to the rate of change. Bars to the left of zero show a reduction in attribution and bars to the right show an increase. LRI=lower respiratory tract infection. DALY=disability-adjusted life-year.
Figure 4
Figure 4
Risk factor decomposition of the change in attributable DALYs in all ages between 2005 and 2015 (A) Southeast Asia, east Asia, and Oceania; (B) north Africa and Middle East; (C) south Asia; (D) central Europe, eastern Europe, and central Asia; (E) sub-Saharan Africa; (F) Latin America and Caribbean; and (G) high-income WHO regions. Black dots show the overall percentage change in LRI DALYs and colours show contribution of different factors to the rate of change. Bars to the left of zero show a reduction in attribution and bars to the right show an increase. LRI=lower respiratory tract infection. DALY=disability-adjusted life-year.
Figure 4
Figure 4
Risk factor decomposition of the change in attributable DALYs in all ages between 2005 and 2015 (A) Southeast Asia, east Asia, and Oceania; (B) north Africa and Middle East; (C) south Asia; (D) central Europe, eastern Europe, and central Asia; (E) sub-Saharan Africa; (F) Latin America and Caribbean; and (G) high-income WHO regions. Black dots show the overall percentage change in LRI DALYs and colours show contribution of different factors to the rate of change. Bars to the left of zero show a reduction in attribution and bars to the right show an increase. LRI=lower respiratory tract infection. DALY=disability-adjusted life-year.

References

    1. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–171.
    1. Bhutta ZA, Das JK, Walker N. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet. 2013;381:1417–1429.
    1. UN Department of Economic and Social Affairs Sustainable Development Goal 3: ensure healthy lives and promote well-being for all at all ages. 2017. (accessed Oct 10, 2016).
    1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–1602.
    1. GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544.
    1. Stevens GA, Alkema L, Black RE. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet. 2016;388:e19–e23.
    1. Naghavi M, Makela S, Foreman K, O'Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr. 2010;8:9.
    1. Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012;10:1.
    1. WHO Department of Child and Adolescent Health and Development . Handbook: integrated management of childhood illness. World Health Organization; Geneva: 2005. (accessed Nov 7, 2016).
    1. Global Burden of Disease Study 2013 Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800.
    1. Vos T, Flaxman AD, Naghavi M. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–2196.
    1. GBD 2015 DALYs and HALE Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1603–1658.
    1. Feikin DR, Scott JA, Gessner BD. Use of vaccines as probes to define disease burden. Lancet. 2014;383:1762–1770.
    1. O'Brien KL, Wolfson LJ, Watt JP. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902.
    1. Watt JP, Wolfson LJ, O'Brien KL. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 2009;374:903–911.
    1. Swingler G, Fransman D, Hussey G. Conjugate vaccines for preventing Haemophilus influenzae type B infections. Cochrane Database Syst Rev. 2007;2 CD001729.
    1. Lucero MG, Dulalia VE, Nillos LT. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev. 2009;4 CD004977.
    1. Bonten MJ, Huijts SM, Bolkenbaas M. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372:1114–1125.
    1. Shi T, McLean K, Campbell H, Nair H. Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: a systematic review and meta-analysis. J Glob Health. 2015;5:010408.
    1. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974;99:325–332.
    1. United Nations Development Programme . Human development report 2015: work for human development. United Nations; New York, NY: 2016. (accessed Nov 10, 2016).
    1. GBD 2015 Risk Factors Collaborators Global, regional and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–1724.
    1. Mokdad AH, Forouzanfar MH, Daoud F. Global burden of diseases, injuries, and risk factors for young people's health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387:2383–2401.
    1. Dherani M, Pope D, Mascarenhas M, Smith KR, Weber M, Bruce N. Indoor air pollution from unprocessed solid fuel use and pneumonia risk in children aged under five years: a systematic review and meta-analysis. Bull World Health Organ. 2008;86:390–398C.
    1. Mehta S, Shin H, Burnett R, North T, Cohen AJ. Ambient particulate air pollution and acute lower respiratory infections: a systematic review and implications for estimating the global burden of disease. Air Qual Atmos Health. 2013;6:69–83.
    1. Olofin I, McDonald CM, Ezzati M. Associations of suboptimal growth with all-cause and cause-specific mortality in children under five years: a pooled analysis of ten prospective studies. PLoS One. 2013;8:e64636.
    1. Das Gupta P. Standardization and decomposition of rates: a user's manual. US Bureau of the Census; Washington DC: 1993.
    1. WHO. The United Nations Children's Fund (UNICEF) Ending preventable child deaths from pneumonia and diarrhoea by 2025: the integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD) World Health Organization; Geneva: 2013. (accessed Nov 7, 2016).
    1. Izadnegahdar R, Cohen AL, Klugman KP, Qazi SA. Childhood pneumonia in developing countries. Lancet Respir Med. 2013;1:574–584.
    1. Soofi S, Ahmed S, Fox MP. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2–59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial. Lancet. 2012;379:729–737.
    1. Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis. 2003;3:547–556.
    1. Graham SM, English M, Hazir T, Enarson P, Duke T. Challenges to improving case management of childhood pneumonia at health facilities in resource-limited settings. Bull World Health Organ. 2008;86:349–355.
    1. Crowther-Gibson P, Cohen C, Klugman KP, de Gouveia L, von Gottberg A. Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008. Antimicrob Agents Chemother. 2012;56:5088–5095.
    1. Kim L, McGee L, Tomczyk S, Beall B. Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective. Clin Microbiol Rev. 2016;29:525–552.
    1. WHO . Immunization coverage. World Health Organization; Geneva: 2016. (accessed Nov 2, 2016).
    1. Progress introducing Haemophilus influenzae type b vaccine in low-income countries, 2004–2008. Wkly Epidemiol Rec. 2008;83:61–67. No authors listed.
    1. Madhi SA, Kuwanda L, Cutland C, Klugman KP. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis. 2005;40:1511–1518.
    1. Rodgers GL, Klugman KP. Surveillance of the impact of pneumococcal conjugate vaccines in developing countries. Hum Vaccin Immunother. 2016;12:417–420.
    1. Prato R, Fortunato F, Martinelli D. Pneumococcal pneumonia prevention among adults: is the herd effect of pneumococcal conjugate vaccination in children as good a way as the active immunization of the elderly? Curr Med Res Opin. 2016;32:543–545.
    1. Stevens GA, Finucane MM, Paciorek CJ. Trends in mild, moderate, and severe stunting and underweight, and progress towards MDG 1 in 141 developing countries: a systematic analysis of population representative data. Lancet. 2012;380:824–834.
    1. Jackson S, Mathews KH, Pulanic D. Risk factors for severe acute lower respiratory infections in children: a systematic review and meta-analysis. Croat Med J. 2013;54:110–121.
    1. UN Department of Economic and Social Affairs Sustainable Development Goal 2: end hunger, achieve food security and improved nutrition and promote sustainable agriculture. 2017. (accessed Oct 7, 2016).
    1. Kurmi OP, Lam KBH, Ayres JG. Indoor air pollution and the lung in low- and medium-income countries. Eur Respir J. 2012;40:239–254.
    1. Mikkelsen L, Phillips DE, AbouZahr C. A global assessment of civil registration and vital statistics systems: monitoring data quality and progress. Lancet. 2015;386:1395–1406.
    1. Scott JA, Brooks WA, Peiris JS, Holtzman D, Mulholland EK. Pneumonia research to reduce childhood mortality in the developing world. J Clin Invest. 2008;118:1291–1300.
    1. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–351.
    1. Resti M, Moriondo M, Cortimiglia M. Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis. 2010;51:1042–1049.
    1. Arnold FW, Summersgill JT, Lajoie AS. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007;175:1086–1093.
    1. Cilloniz C, Martin-Loeches I, Garcia-Vidal C, San Jose A, Torres A. Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns. Int J Mol Sci. 2016;17:E2120.
    1. Levine OS, O'Brien KL, Deloria-Knoll M. The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study. Clin Infect Dis. 2012;54(suppl 2):S93–101.
    1. Dowell SF, Garman RL, Liu G, Levine OS, Yang YH. Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients. Clin Infect Dis. 2001;32:824–825.
    1. Hill PC, Akisanya A, Sankareh K. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis. 2006;43:673–679.
    1. Radin JM, Katz MA, Tempia S. Influenza surveillance in 15 countries in Africa, 2006–2010. J Infect Dis. 2012;206(suppl 1):S14–S21.
    1. Johns Hopkins Bloomberg School of Public Health Maternal and child epidemiology estimation. (accessed Aug 26, 2016).
    1. WHO Estimates for 2000–2015. Geneva: World Health Organization. (accessed Aug 25, 2016).
    1. AbouZahr C, de Savigny D, Mikkelsen L. Civil registration and vital statistics: progress in the data revolution for counting and accountability. Lancet. 2015;386:1373–1385.

Source: PubMed

3
Se inscrever